Prognostic potential of detection of WT1 mRNA level in peripheral blood in adult acute myeloid leukemia-Reference-Cited by-同舟云学术

Prognostic potential of detection of WT1 mRNA level in peripheral blood in adult acute myeloid leukemia

Published:2010-09-20 Issue:10 Volume:51 Page:1855-1861
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Miyawaki Shuichi,Hatsumi Nahoko,Tamaki Toshiharu,Naoe Tomoki,Ozawa Keiya,Kitamura Kunio,Karasuno Takahiro,Mitani Kinuko,Kodera Yoshihisa,Yamagami Tamotsu,Koga Daisuke

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2010.507829

Reference20 articles.

1. Randomized study of individualized induction therapy with or without vincristine, and of maintenance—intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML-87 study of the Japan adult leukemia study group

2. Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group.

3. 6-Thioguanine, Cytarabine, and Daunorubicin (TAD) and High-Dose Cytarabine and Mitoxantrone (HAM) for Induction, TAD for Consolidation, and Either Prolonged Maintenance by Reduced Monthly TAD or TAD-HAM-TAD and One Course of Intensive Consolidation by Sequential HAM in Adult Patients at All Ages With De Novo Acute Myeloid Leukemia (AML): A Randomized Trial of the German AML Cooperative Group

4. Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of peripheral blood WT1 mRNA dynamics in patients with acute myeloid leukemia treated with venetoclax combination therapy;International Journal of Clinical Oncology;2024-02-09

2. Primary testicular lymphoma demonstrates overexpression of the Wilms tumor 1 gene and different mRNA and miRNA expression profiles compared to nodal diffuse large B‐cell lymphoma;Hematological Oncology;2023-06-08

3. Clinical significance of the increased expression of the WT1 gene in peripheral blood of patients with acquired aplastic anemia;eJHaem;2022-09-20

4. NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemia;International Journal of Hematology;2022-04-04

5. Dynamic change in peripheral blood WT1 mRNA levels within three cycles of azacitidine predict treatment response in patients with high-risk myelodysplastic syndromes;Annals of Hematology;2022-03-08